HOME >> MEDICINE >> NEWS
The European Cancer Patient Coalition - challenges for the future

The emergence of cross-Europe policies on health and related issues mean that cancer patients need a voice at European level, said a leading patient advocate at ECCO 12 The European Cancer Conference in Copenhagen today (Tuesday 23 September). But, according to Kathy Redmond, Editor, Cancer Futures, from Milan, Italy, there are many challenges to be faced in building an effective patient organisation, and the newly-launched European Cancer Patient Coalition (ECPC) will have to consider how best to tackle them.

At a European level it is difficult to define common concerns because of the variability of health care systems, she said. The European legislative system is extremely complicated, even to Brussels insiders, and ECPC will have to learn how to navigate and influence it.

But one of the largest obstacles to patient collaboration at European level is language. "Relatively few Europeans have the same mother tongue, with just over 25% speaking German, and 16% speaking English. Just over 50% of Europeans claim to speak a second language with around 40% speaking English, 10% German, 7% Spanish, and 3% Italian." Additionally, fluency in English as a second language declines with age, Ms Redmond said.

Linguistic difficulties also contribute to the digital divide in Europe. "Given that 70% of the content of the internet is in English, it is not surprising that there is a huge variation in the number of houses with internet access across Europe. In countries with high levels of English fluency such as the Netherlands, Sweden and Denmark, around 65% of households have internet access. But in Greece, Spain and Portugal internet access at home is as low as 9%. According to the latest Eurobarometer study, an average of only 25% of Europeans get health information from the internet," she said.

Funding is another problem for patient organisations, and one of the biggest challenges facing ECPC will be to ensure adequate funding to overcome th
'"/>

Contact: Mary Rice
mary.rice@blueprintpartners.be
45-3252-4163
Federation of European Cancer Societies
23-Sep-2003


Page: 1 2

Related medicine news :

1. ESC releases the first European Guidelines on Percutaneous Coronary Interventions (PCI)
2. The European Society of Cardiology launches Women at Heart
3. Use of potentially inappropriate medications among elderly common in some European countries
4. European folic acid policies are not effective enough
5. New European cancer figures for 2004 major efforts needed against the big four killers
6. Third of European cancer patients use complementary and alternative therapies
7. A new service from the European Patent Office
8. European study highlights persistent 3 decade increase in childhood cancer incidence
9. European nations urged to ratify international treaty on tobacco control
10. Increased investment in radiotherapy will improve cure rates for European cancer patients
11. ESA looking for more European women to volunteer for WISE bed-rest study in Toulouse next year

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The European Cancer Patient Coalition challenges for the future

(Date:2/28/2015)... The MCA Youth Empowerment Conference aims to ... and gears towards the goal for a better future ... talks in smaller groups will be held after the ... Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women and Youth ... , Young adults aged between 18-30 years ...
(Date:2/28/2015)... In a recent episode of SCI TV ... Athlete Development Services and Consultancy talks with Joshua ... development and player engagement during and after their careers. ... face and how off-field activities are a critical component ... in athlete development issues while in graduate school coaching ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The Heart ... now a distributor of the machine. The Heart Fit ... their license, like a franchise model. The goal is ... and reverse heart disease. To buy External Counterpulsation ... Clinic can help individuals through this process and achieve ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax ... business consulting services in addition to a variety of ... succession planning. Company finances are a complicated matter that ... of this, complex Canadian tax laws can make it ... result, Mew and Company works to advise their clients ...
(Date:2/28/2015)... CA (PRWEB) February 28, 2015 A ... a promising new gene therapy procedure for the treatment ... blindness in patients. Authored by Dr. Robert ... and published in the Lancet Medical Journal on January ... from choroideremia, a rare genetic disorder that mostly affects ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2
(Date:2/27/2015)... Roughly three-quarters of pharmacists said they ... interchangeable biosimilar for its branded biologic counterpart if ... according to a survey published in the Academy ... Managed Care & Specialty Pharmacy (JMCP). ... would feel as confident if the products had ...
(Date:2/27/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a leading open-access ... biotechnology, and medical device industries with operations in ... States , congratulates our partner TaiMed Biologics for ... ibalizumab (TMB355). The FDA designates a drug as a ... combination with one or more other drugs, to treat ...
(Date:2/27/2015)... Feb. 27, 2015  Acsis Inc., the market leader ... announced today that John DiPalo , Acsis, Chief ... & Demand Chain Executive 2015 Provider Pro to ... leading initiatives to help prepare their companies, and customers, ... climate. This year,s list of Provider Pros to Know ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2
Cached News: